We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RUM:NASDAQRumble Inc. Analysis

Data as of 2026-04-29 - not real-time

$7.01

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Rumble Inc. is trading at $7.01, comfortably above its 20‑day SMA of 5.81 and 50‑day SMA of 5.56, suggesting a short‑term uptrend. The RSI of 66.9 confirms momentum without being overbought, while the MACD histogram is positive (0.16) and the signal line is bullish, reinforcing technical strength. However, the stock exhibits a 30‑day volatility of 74.7% and a computed beta of 2.66, indicating pronounced price swings and high market sensitivity. Fundamentally, Rumble shows deep weakness: negative gross margin (-6.7%), operating margin (-89.4%), and a trailing EPS of -0.32, with a forward PE of -22.6 and a price‑to‑book of 8.65, far above its book value. The company’s cash position (~$238 M) is modest relative to its free‑cash‑flow deficit (~$215 M), and the debt‑to‑equity ratio of 0.70 adds leverage risk. Recent material news highlights a strategic push into AI infrastructure, the launch of the OpenClaw Starter package on Rumble Cloud, and the appointment of a new CFO with deep AI and hyperscale experience, all of which could catalyze top‑line growth. Despite these initiatives, the current financial profile remains fragile, and the market’s “Extreme Greed” sentiment (fear‑greed index 89.6) may be overstating upside. The model‑derived upside/downside potential of +214%/-55% reflects high uncertainty. Investors should weigh the technical bullishness against the stark earnings and cash‑flow deficits before deciding.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish technical indicators (SMA, MACD, RSI)
  • High volatility and beta increasing price risk
  • Negative earnings and cash‑flow metrics

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Strategic AI infrastructure positioning and OpenClaw launch
  • New CFO with AI and hyperscale expertise
  • Potential top‑line growth outweighing current losses if execution succeeds

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustained profitability challenges and high valuation multiples
  • Exposure to regulatory scrutiny in content and crypto domains
  • Uncertain path to cash‑flow positivity despite growth initiatives

Key Metrics & Analysis

Financial Health

Revenue Growth-10.50%
Profit Margin-81.32%
P/E Ratio-22.6
ROE-77.30%
ROA-26.47%
Debt/Equity0.70
P/B Ratio8.7
Op. Cash Flow$-70430152
Free Cash Flow$-215264848
Industry P/E18.7

Technical Analysis

TrendNeutral
RSI66.9
Support$4.72
Resistance$7.30
MA 20$5.81
MA 50$5.56
MA 200$6.75
MACDBullish
VolumeIncreasing
Fear & Greed Index89.59

Valuation

Target Price$22.00
Upside/Downside213.84%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.66
Volatility74.72%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.